SHA:600521 Market Cap

SHA:600521 has a market cap or net worth of 23.56 billion as of March 9, 2026. Its market cap has increased by 4.29% in one year.

Market Cap

23.56B

Enterprise Value

29.84B

Revenue

8.71B

Ranking

n/a

PE Ratio

49.54

Stock Price

15.81

Market Cap Chart

Since March 4, 2003, SHA:600521's market cap has increased from 3.97B to 23.56B, an increase of 493.34%. That is a compound annual growth rate of 8.04%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	23.83B	-5.77%
Dec 31, 2025	25.29B	-2.34%
Dec 31, 2024	25.89B	19.93%
Dec 29, 2023	21.59B	-33.42%
Dec 30, 2022	32.43B	0.57%
Dec 31, 2021	32.25B	-34.43%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Dizal (Jiangsu) Pharmaceutical	23.58B
Jiangsu Nhwa Pharmaceutical Co., LTD	23.04B
Wedge Industrial	21.88B
Hubei Jumpcan Pharmaceutical	25.57B
Chengdu Kanghong Pharmaceutical Group	25.61B
Jilin Aodong Pharmaceutical Group	21.52B
Kangmei Pharmaceutical	25.86B
Tasly Pharmaceutical Group	21.02B

Market Cap Rankings